related words |
unproven |
protein |
tm |
therapeutic |
distributing |
discovered |
pti |
tarceva |
gene |
nexavar |
surgeon |
novel |
hematide |
stent |
undergo |
esw |
recothrom |
formulation |
bidil |
myvax |
|
related documents |
1359555--3/28/2008--ICO_Global_Communications_(Holdings)_LTD |
1318310--2/25/2010--ev3_Inc. |
1065059--3/1/2010--USEC_INC |
879169--3/5/2010--INCYTE_CORP |
1065059--2/26/2009--USEC_INC |
879169--3/3/2009--INCYTE_CORP |
879169--3/6/2008--INCYTE_CORP |
1029142--3/17/2008--DYNAVAX_TECHNOLOGIES_CORP |
1103345--3/17/2008--BEACON_POWER_CORP |
879169--2/28/2007--INCYTE_CORP |
1103345--3/30/2007--BEACON_POWER_CORP |
1273013--3/20/2006--PHARMACOPEIA_DRUG_DISCOVERY_INC |
1100412--8/12/2010--ARRAY_BIOPHARMA_INC |
716646--6/14/2010--CLINICAL_DATA_INC |
881524--3/10/2010--VIVUS_INC |
1405424--3/29/2010--VISION_INDUSTRIES_CORP |
1142596--2/26/2010--NUVASIVE_INC |
356591--3/26/2010--NEUROLOGIX_INC/DE |
901219--3/2/2010--HUMAN_GENOME_SCIENCES_INC |
1095565--3/26/2010--HEALTHSTREAM_INC |
|
related topics |
{product, candidate, development} |
{product, liability, claim} |
{control, financial, internal} |
{customer, product, revenue} |
{investment, property, distribution} |
{tax, income, asset} |
{financial, litigation, operation} |
{interest, director, officer} |
{capital, credit, financial} |
{property, intellectual, protect} |
{acquisition, growth, future} |
{competitive, industry, competition} |
{cost, contract, operation} |
{gas, price, oil} |
{stock, price, share} |
{operation, natural, condition} |
{system, service, information} |
{regulation, government, change} |
{product, market, service} |
{debt, indebtedness, cash} |
|